U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06807151) titled 'Leveraging Plasma Concentration Levels to Optimize Extracorporeal Treatment in Acute Diquat Poisoning' on Jan. 29.
Brief Summary: This study aimed to evaluate the clinical value of plasma diquat (DQ) concentration in guiding personalized extracorporeal treatment (ECTR) regimens for patients with acute DQ poisoning.
Study Start Date: Feb. 01, 2022
Study Type: OBSERVATIONAL
Condition:
Diquat Poisoning
Blood Purification
Intervention:
PROCEDURE: extracorporeal treatment
Extracorporeal treatments included hemoperfusion and continuous veno-venous hemodiafiltration.
Recruitment Status: COMPLETED
Sponsor: The Affiliated Nanjing Dru...